FDA OKs Invossa brand name for Rockville’s TissueGene

Rockville-based TissueGene, Inc. reported Wednesday that the U.S. Food and Drug Administration  has accepted the proposed brand name Invossa for TissueGene-C, the company’s proprietary product in development for treatment of osteoarthritis of the knee. The FDA’s acceptance of the proprietary brand name is subject to the agency’s final determination prior to any approval of the ...

Leave a Reply

Your email address will not be published. Required fields are marked *